You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Authors' response
  1. K S Boparai1,
  2. J B Reitsma2,
  3. E Dekker1
  1. 1Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
  2. 2Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands
  1. Correspondence to Evelien Dekker, Department of Gastroenterology and Hepatology, Academic Medical Center, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands; e.dekker{at}amc.uva.nl

https://doi.org/10.1136/gut.2010.227280

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Patients with hyperplastic polyposis syndrome (HPS) harbour multiple colorectal hyperplastic polyps and are at risk of developing colorectal cancer (CRC).1–6 In a recent study we determined the RR of CRC (5.4; 95% CI 3.7 to 7.8) and HPS (39; 95% CI 13 to 121) in first-degree relatives (FDRs) of patients with HPS compared with the general population.7 Win et al raised concerns that probands in our study might have been ‘preferentially ascertained because of a known family history (to any degree of genetic relatedness) of CRC’ which would lead to an ascertainment bias. This would then overestimate the familial risk of CRC.

    As discussed in the original paper, the majority of probands included in our cohort were symptomatic and thus did not encompass preferentially ascertained individuals with …

    View Full Text

    Footnotes

    • Linked articles 223826.

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles